Study on the effect of a combination therapy of H2 receptor antagonist and 5-HT3 receptor antagonist for the treatment of dyspepsia with mild irritable bowel syndrome
Not Applicable
- Conditions
- Male dyspepsia with mildly diarrheal IBS
- Registration Number
- JPRN-UMIN000003963
- Lead Sponsor
- Hyogo College of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patient who has a history of hypersensitivity 2.Patient who has organic illness such as gastroduodenal ulcer, gastric cancer, intestinal cancer or imflammatory bowel disease 3.Patient with chronic constipation or constipated IBS 4.Patient who is currently receiving H2RA, PPI or drugs for IBS 5.Patient who has renal disorder 6.Patient who has cardiovascular diseases 7.Patient who has hepatic disorder 8.Patient who is pregnant nursing mom 9.Patient wit whome the physicina-in-charge considered inappropriate as a subject of the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method